News
Breaking News
FDA Clears Opus Genetics’ IND Application for Gene Therapy Candidate for Rare Inherited Retinal Disease
Dec 05, 2022
According to a statement from Opus Genetics, the FDA has approved its investigational new drug (IND) application for a phase 1/2, first-in-human clini
Aldeyra Therapeutics Submits NDA for Reproxalap for Treatment of Signs and Symptoms of DED
Nov 30, 2022
Aldeyra Therapeutics has submitted a new drug application (NDA) to the FDA for topical ocular reproxalap, an investigational new drug candidate for th
Industry News
Harrow Expands National Product Supply Agreement with iOR Partners
Dec 01, 2022
Harrow and iOR Partners have expanded their national product supply agreement to provide Harrow’s entire formulary compounded ophthalmic products to i
Ophthalmology Day Set to Take Place Virtually on November 29
Nov 29, 2022
Global financial services firm BTIG announced that "Ophthalmology Day at BTIG" will take place on November 29, 2022. The virtual, 1-day event will inc
Popular
The Use of Durysta (Bimatoprost) and Its Effects
Dec 06, 2022
Bimatoprost is a medicine that helps with high pressure in the eye (OCT) and open-angle glaucoma. When too much fluid builds up in your eyes the press
Retinal Pattern Dystrophies
Dec 05, 2022
Retinal pattern dystrophies, as the name implies, are a group of disorders characterized by diverse pigment deposition patterns in the macula's retina
Editor's Pick
What is a Trabectome? Is the Surgery Risky?
Dec 02, 2022
Trabectome surgery increases the amount of fluid exiting the eye, helping to lower the pressure of the eye.
What Is DURYSTA Implant?
Dec 01, 2022
DURYSTA is a totally biodegradable implant applied to an eye affected by glaucoma or high eye pressure. It’s a drug under the class of Prostaglandin Analogs.
Genetics and Long Years of Schooling Can Lead to Myopia in Children
Nov 28, 2022
Researchers have discovered five genetic variations that steadily increase children’s likelihood of developing nearsightedness the longer they attend school. These findings were published on November 17 in the open access journal PLOS Genetics.
ESCRS 2022
Special ESCRS Interview With Dr. Carlos Ruiz Lapuente
Oct 04, 2022
Carlos Ruiz Lapuente is an experienced surgeon in combined procedures of cataract, glaucoma, and vitreoretinal diseases.
Interview: Co-Founder Morena Gomedi Unveils Details of Espansione Group’s Newest Technology
Sep 21, 2022
Founded in 1981, Espansione Group designs and manufactures a wide range of innovative devices and solutions in the fields of ophthalmology and dermatology.
Several Satellite Symposia Planned for the 3rd Day of the ESCRS Congress
Sep 18, 2022
The third day of the ESCRS Congress will be marked with several important satellite symposia, in which global eyecare companies will introduce case studies and clinical results of their newly-launched ophthalmic products with clinical experts.
Ophthalmology Breaking News Subscribe